ArticlePharmacological research2025

Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models.

Christopher Douglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.